BBA
Baker Bros. Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6M | Buy |
370,208
+22,800
| +7% | +$714K | 0.11% | 50 |
|
|
2025
Q1 | $11.7M | Sell |
347,408
-646,271
| -65% | -$21.7M | 0.13% | 43 |
|
|
2024
Q4 | $39M | Hold |
993,679
| – | – | 0.42% | 30 |
|
|
2024
Q3 | $39.1M | Hold |
993,679
| – | – | 0.41% | 29 |
|
|
2024
Q2 | $38.7M | Hold |
993,679
| – | – | 0.5% | 27 |
|
|
2024
Q1 | $42.8M | Hold |
993,679
| – | – | 0.54% | 30 |
|
|
2023
Q4 | $45.8M | Buy |
993,679
+242,040
| +32% | +$11.1M | 0.52% | 24 |
|
|
2023
Q3 | $25.7M | Hold |
751,639
| – | – | 0.15% | 33 |
|
|
2023
Q2 | $28.9M | Hold |
751,639
| – | – | 0.17% | 34 |
|
|
2023
Q1 | $26.9M | Hold |
751,639
| – | – | 0.15% | 32 |
|
|
2022
Q4 | $29.6M | Hold |
751,639
| – | – | 0.18% | 31 |
|
|
2022
Q3 | $27.1M | Hold |
751,639
| – | – | 0.18% | 37 |
|
|
2022
Q2 | $22.9M | Hold |
751,639
| – | – | 0.13% | 44 |
|
|
2022
Q1 | $23M | Hold |
751,639
| – | – | 0.13% | 50 |
|
|
2021
Q4 | $23.5M | Hold |
751,639
| – | – | 0.11% | 54 |
|
|
2021
Q3 | $11.5M | Hold |
751,639
| – | – | 0.05% | 77 |
|
|
2021
Q2 | $14M | Hold |
751,639
| – | – | 0.06% | 71 |
|
|
2021
Q1 | $13.5M | Buy |
751,639
+64,253
| +9% | +$1.15M | 0.06% | 69 |
|
|
2020
Q4 | $10.6M | Sell |
687,386
-72,922
| -10% | -$1.12M | 0.04% | 73 |
|
|
2020
Q3 | $8.42M | Sell |
760,308
-38,794
| -5% | -$429K | 0.03% | 70 |
|
|
2020
Q2 | $10M | Buy |
+799,102
| New | +$10M | 0.04% | 60 |
|